Decibel Therapeutics Appoints Kevin F. McLaughlin to its Boa

12.10.2022 - BOSTON, Oct. 12, 2022 (GLOBE NEWSWIRE) - Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced the ... Seite 1

Related Keywords

Acceleron Pharma , Merck Co Inc , Glaxosmithkline , Northeastern University , Computervision Corporation , Qteros Inc , Vericel Corporation , Aptius Education Inc , Senior Vice , Chief Financial Officer , Chief Operating Officer , Aptius Education , Chief Executive Officer , Stealth Bio Therapeutics , Prime Computer , Graduate School , Decibel Board ,